Miyakogusa Predicted Gene
- Lj0g3v0094009.1
BLASTP 2.2.25 [Feb-01-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= Lj0g3v0094009.1 Non Characterized Hit- tr|I1L3T6|I1L3T6_SOYBN
Uncharacterized protein OS=Glycine max PE=4
SV=1,66.83,0,Kunitz_legume,Proteinase inhibitor I3, Kunitz legume; no
description,NULL; STI-like,Kunitz inhibitor,gene.g7155.t1.1
(199 letters)
Database: Medicago_aa4.0v1
62,319 sequences; 21,947,249 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
Medtr6g078290.1 | Lipid transfer protein | HC | chr6:29387667-29... 211 3e-55
Medtr6g078280.1 | Kunitz type trypsin inhibitor / miraculin | HC... 205 3e-53
Medtr6g078120.1 | Kunitz type trypsin inhibitor / miraculin | HC... 193 7e-50
Medtr6g078140.1 | Kunitz type trypsin inhibitor / miraculin | HC... 193 9e-50
Medtr6g078250.1 | Kunitz type trypsin inhibitor / miraculin | HC... 190 9e-49
Medtr7g037410.1 | Nodule Cysteine-Rich (NCR) secreted peptide | ... 168 4e-42
Medtr6g078260.1 | Kunitz type trypsin inhibitor / miraculin | HC... 157 5e-39
Medtr6g078070.1 | Kunitz type trypsin inhibitor / miraculin | HC... 142 2e-34
Medtr6g078100.1 | Kunitz type trypsin inhibitor / miraculin | HC... 132 2e-31
Medtr6g065460.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 84 1e-16
Medtr8g461050.1 | Kunitz type trypsin inhibitor | HC | chr8:2137... 82 4e-16
Medtr3g106620.1 | Kunitz type trypsin inhibitor | HC | chr3:4927... 82 4e-16
Medtr6g066190.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 80 2e-15
Medtr6g009650.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 79 3e-15
Medtr6g009563.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 79 3e-15
Medtr0100s0150.1 | Kunitz type trypsin inhibitor | HC | scaffold... 77 8e-15
Medtr8g059790.1 | Kunitz type trypsin inhibitor | HC | chr8:2193... 77 1e-14
Medtr3g106585.1 | Kunitz type trypsin inhibitor | HC | chr3:4927... 77 2e-14
Medtr2g072980.1 | Kunitz type trypsin inhibitor | HC | chr2:3087... 76 2e-14
Medtr7g108815.1 | Kunitz type trypsin inhibitor | HC | chr7:4444... 76 2e-14
Medtr2g073010.1 | Kunitz type trypsin inhibitor | HC | chr2:3090... 76 2e-14
Medtr3g014820.1 | Kunitz type trypsin inhibitor | HC | chr3:4286... 74 6e-14
Medtr3g014870.1 | Kunitz type trypsin inhibitor | HC | chr3:4294... 74 8e-14
Medtr8g461690.1 | Kunitz type trypsin inhibitor | HC | chr8:2179... 74 1e-13
Medtr8g060550.1 | Kunitz type trypsin inhibitor | HC | chr8:2140... 74 1e-13
Medtr0302s0030.1 | Kunitz type trypsin inhibitor | HC | scaffold... 73 2e-13
Medtr6g059650.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 72 4e-13
Medtr0211s0080.1 | Kunitz type trypsin inhibitor | HC | scaffold... 72 5e-13
Medtr0084s0030.1 | Kunitz type trypsin inhibitor | HC | scaffold... 70 1e-12
Medtr6g017225.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 69 2e-12
Medtr6g059680.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 67 8e-12
Medtr6g066210.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 67 2e-11
Medtr6g059730.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 65 3e-11
Medtr6g059760.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 65 4e-11
Medtr6g078040.1 | kunitz family trypsin and protease inhibitor p... 64 1e-10
Medtr6g059530.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 57 8e-09
Medtr6g059410.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 56 2e-08
Medtr6g065460.2 | Kunitz type trypsin inhibitor / Alpha-fucosida... 54 8e-08
Medtr6g059810.1 | Kunitz type trypsin inhibitor / Alpha-fucosida... 49 3e-06
>Medtr6g078290.1 | Lipid transfer protein | HC |
chr6:29387667-29389179 | 20130731
Length = 213
Score = 211 bits (538), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 102/190 (53%), Positives = 133/190 (70%), Gaps = 13/190 (6%)
Query: 21 GSAGPTPKEVFDSSGKNLRAGTQYYI--IPASP-DADGLSLANTG---------KDCPLD 68
G A +P++V D+ GK +RAG YYI +P +P D G + +G + CPL+
Sbjct: 21 GEADASPEQVVDTEGKKVRAGVDYYIRPVPTTPCDGRGPCVVGSGFVLIARSPNETCPLN 80
Query: 69 AVAVEGYRGLPLVFTPVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFV 128
V VEG+RG + FTPVNPKKGV+RV TDLNI + TSC +S +W + D+DS+TGQWFV
Sbjct: 81 VVVVEGFRGQGVTFTPVNPKKGVIRVSTDLNIKTSLNTSCEESTIWTLDDFDSSTGQWFV 140
Query: 129 TTGGVFGDPGLQTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYG-KRLAL 187
TTGGV G+PG T+ NWFKIE+YED YK +CP+VC C +CR++GI+ D G +R+AL
Sbjct: 141 TTGGVLGNPGKDTVDNWFKIEKYEDDYKFVFCPTVCNFCKVMCRNVGIFRDSNGNQRVAL 200
Query: 188 TDVPYKVRFQ 197
TDVPYKVRFQ
Sbjct: 201 TDVPYKVRFQ 210
>Medtr6g078280.1 | Kunitz type trypsin inhibitor / miraculin | HC |
chr6:29385612-29386426 | 20130731
Length = 212
Score = 205 bits (521), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 107/194 (55%), Positives = 134/194 (69%), Gaps = 17/194 (8%)
Query: 21 GSAGPTPKEVFDSSGKNLRAGTQYYIIPASP----------DADGLSLANTGKDCPLDAV 70
GSA +P +V D+SGK LRA T YYIIPA P ++ G++L G+ CPLD V
Sbjct: 21 GSAEASPDQVIDTSGKKLRADTNYYIIPAKPFTTCGFVSCFNSGGIALETVGESCPLDVV 80
Query: 71 AVEGYRGLPLVFTPVNPKKGVVRVDTDLNIYF---AAETSCP-QSNVWKVSDYDSATGQW 126
V+ +GLPL FTPVN KKGVVRV TDLNI F A ++ CP S VWK+ + +
Sbjct: 81 VVKHNQGLPLRFTPVNNKKGVVRVSTDLNIKFSNDAYDSRCPNHSLVWKIDPFSKE--ET 138
Query: 127 FVTTGGVFGDPGLQTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGK-RL 185
FVTT GV G+PG TI NWF+IE+YEDAYKL YCP+VC SC H+C+D+GIY +Y + RL
Sbjct: 139 FVTTNGVLGNPGSNTIHNWFQIEKYEDAYKLVYCPNVCPSCKHVCKDIGIYVYKYREMRL 198
Query: 186 ALTDVPYKVRFQLA 199
ALT+VP+KV+FQ A
Sbjct: 199 ALTNVPFKVKFQKA 212
>Medtr6g078120.1 | Kunitz type trypsin inhibitor / miraculin | HC |
chr6:29339427-29340198 | 20130731
Length = 213
Score = 193 bits (491), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 100/192 (52%), Positives = 130/192 (67%), Gaps = 13/192 (6%)
Query: 21 GSAGPTPKEVFDSSGKNLRAGTQYYIIPASPDADG-----------LSLANTGKDCPLDA 69
G+A + ++V D+ GK LRA YYIIP G L+LA+ GK CPLD
Sbjct: 22 GAAEASNEQVVDTLGKKLRADANYYIIPVPIYKCGPYGKCRSSGSSLALASNGKTCPLDV 81
Query: 70 VAVEGYRGLPLVFTPVNPKKGVVRVDTDLNIYFAAETSC-PQSNVWKVSDYDSATGQWFV 128
V V+ Y+ LPL F PVNPKKGV+RV TDLNI F++ +C S VWK+ ++ + QWF+
Sbjct: 82 VVVDRYQALPLTFIPVNPKKGVIRVSTDLNIKFSSRATCLHHSMVWKLDRFNVSKRQWFI 141
Query: 129 TTGGVFGDPGLQTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYG-KRLAL 187
T GGV G+PG +TI NWFKIE+Y DAYKL +CPSV S H+C+D+G++ D+ G KRLAL
Sbjct: 142 TIGGVAGNPGWETINNWFKIEKYGDAYKLVFCPSVVQSFKHMCKDVGVFVDENGNKRLAL 201
Query: 188 TDVPYKVRFQLA 199
+DVP KV+FQ A
Sbjct: 202 SDVPLKVKFQQA 213
>Medtr6g078140.1 | Kunitz type trypsin inhibitor / miraculin | HC |
chr6:29343542-29342602 | 20130731
Length = 213
Score = 193 bits (490), Expect = 9e-50, Method: Compositional matrix adjust.
Identities = 100/192 (52%), Positives = 130/192 (67%), Gaps = 13/192 (6%)
Query: 21 GSAGPTPKEVFDSSGKNLRAGTQYYIIPASPDADG-----------LSLANTGKDCPLDA 69
G+A + ++V D+ GK LRA YYIIP G L+LA+ GK CPLD
Sbjct: 22 GAAEASNEQVVDTLGKKLRADANYYIIPVPIYKCGPYGKCRSSGSSLALASIGKTCPLDV 81
Query: 70 VAVEGYRGLPLVFTPVNPKKGVVRVDTDLNIYFAAETSC-PQSNVWKVSDYDSATGQWFV 128
V V+ Y+ LPL F PVNPKKGV+RV TDLNI F++ +C S VWK+ ++ + QWF+
Sbjct: 82 VVVDRYQALPLTFIPVNPKKGVIRVSTDLNIKFSSRATCLHHSMVWKLDRFNVSKRQWFI 141
Query: 129 TTGGVFGDPGLQTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYG-KRLAL 187
T GGV G+PG +TI NWFKIE+Y DAYKL +CPSV S H+C+D+G++ D+ G KRLAL
Sbjct: 142 TIGGVAGNPGWETINNWFKIEKYGDAYKLVFCPSVVQSFKHMCKDVGVFVDENGNKRLAL 201
Query: 188 TDVPYKVRFQLA 199
+DVP KV+FQ A
Sbjct: 202 SDVPLKVKFQQA 213
>Medtr6g078250.1 | Kunitz type trypsin inhibitor / miraculin | HC |
chr6:29375539-29376205 | 20130731
Length = 204
Score = 190 bits (482), Expect = 9e-49, Method: Compositional matrix adjust.
Identities = 90/177 (50%), Positives = 125/177 (70%), Gaps = 8/177 (4%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPASP-----DADGLSLANT-GKDCPLDAVAVEGYRGLPLV 81
+ V D +GKNLRA Y ++ + P +GL L+N G+ CPLD + V Y+ LP+
Sbjct: 25 EHVVDITGKNLRANAYYNVLLSMPYTNSRSPEGLGLSNNIGQPCPLDVIVVSRYQSLPIR 84
Query: 82 FTPVNPKKGVVRVDTDLNIYFAAETSCP-QSNVWKVSDYDSATGQWFVTTGGVFGDPGLQ 140
FTP+N KKGV+RV +DLNI F + +SCP + VWK+ +D++ G+ FVTT G G+PG Q
Sbjct: 85 FTPLNLKKGVIRVSSDLNIMFRSNSSCPYHTTVWKLDRFDASKGKSFVTTDGFIGNPGPQ 144
Query: 141 TIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYG-KRLALTDVPYKVRF 196
+I NWFKIE+Y + YKL YCP VC SC H C+++G++ED+ G KRLAL+DVPY+V+F
Sbjct: 145 SISNWFKIEKYVEGYKLVYCPIVCPSCKHECKNVGLFEDENGNKRLALSDVPYQVKF 201
>Medtr7g037410.1 | Nodule Cysteine-Rich (NCR) secreted peptide | HC
| chr7:13787410-13788027 | 20130731
Length = 205
Score = 168 bits (425), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 85/179 (47%), Positives = 113/179 (63%), Gaps = 8/179 (4%)
Query: 27 PKEVFDSSGKNLRAGTQYYIIPASPDADG---LSLANTGKDCPLDAVAVEGYRGLPLVFT 83
P+EV D+SG +R Y+I+P+S ++L NT K CPLD V E + F
Sbjct: 26 PEEVRDTSGNLVRNSINYFILPSSIQCGTRCEMALLNTNKTCPLDVV--EEEEAMQFSFV 83
Query: 84 PVNPKKGVVRVDTDLNIYFAAETSCPQSNV--WKVSDYDSATGQWFVTTGGVFGDPGLQT 141
P N KKGV+RV TDLN+ + T+C S+V WKV D AT Q FVTTGGV G+PG +T
Sbjct: 84 PFNFKKGVIRVSTDLNVIHSFPTNCSTSSVTVWKVDKVDVATSQRFVTTGGVQGNPGRET 143
Query: 142 IRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQ-YGKRLALTDVPYKVRFQLA 199
+ NWFKIER+E YKL +CP+VC C +C+D+GI+ D+ R L+D P+ V+FQ A
Sbjct: 144 VDNWFKIERFESGYKLVFCPTVCRECEVVCKDIGIFLDENRNTRFVLSDFPFGVKFQRA 202
>Medtr6g078260.1 | Kunitz type trypsin inhibitor / miraculin | HC |
chr6:29378378-29378977 | 20130731
Length = 199
Score = 157 bits (397), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 88/183 (48%), Positives = 113/183 (61%), Gaps = 11/183 (6%)
Query: 22 SAGPTPKEVFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKDCPLDAVAVEGYRGL--P 79
S+ + +V D SGK LR + YYIIPA+ L ++ G+ CPL V V+ +GL P
Sbjct: 23 SSKTSLNQVLDISGKKLRTDSDYYIIPANGGDISLE-SSIGESCPLHVVVVKHRQGLGFP 81
Query: 80 LVFTPVNPKKGVVRVDTDLNIYFAA-ETSCPQ-SNVWKVSDYDSATGQWFVTTGGVFGDP 137
L PV KG +RV TDLNI + CP S VWK+ Y FVTT G+ G P
Sbjct: 82 LRLAPV---KGDIRVSTDLNIMLGNYDDRCPNYSVVWKIDPYSKEAT--FVTTNGILGHP 136
Query: 138 GLQTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYE-DQYGKRLALTDVPYKVRF 196
G +I +WFKIE+YEDAYKL YCP+VC SC H+C+D+GIY+ RLALT+VP K++F
Sbjct: 137 GSNSIHSWFKIEKYEDAYKLVYCPNVCPSCNHVCKDIGIYKYKNREMRLALTNVPLKIKF 196
Query: 197 QLA 199
Q A
Sbjct: 197 QQA 199
>Medtr6g078070.1 | Kunitz type trypsin inhibitor / miraculin | HC |
chr6:29323925-29323018 | 20130731
Length = 203
Score = 142 bits (358), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 80/183 (43%), Positives = 112/183 (61%), Gaps = 12/183 (6%)
Query: 27 PKEVFDSSGKNLRAGTQYYIIPA-SPDADGLSLANTGKD---CPLDAV--AVEGYRGLPL 80
P+ V D SGK L G +YYI+P GL++AN G++ CPL V +E G +
Sbjct: 23 PEPVLDISGKQLTTGVKYYILPVIRGKGGGLTVANHGENNQTCPLYVVQEKLEVKNGEAV 82
Query: 81 VFTPVNPKKGVVRVDTDLNIY-FAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGL 139
FTP N K+GV+ TDLNI F +T CPQ+ VWK+ TG WF+ TGGV G+P +
Sbjct: 83 TFTPYNAKQGVILTSTDLNIKSFVTKTKCPQTQVWKL--LKELTGVWFLATGGVEGNPSM 140
Query: 140 QTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYG-KRLALTD-VP-YKVRF 196
T+ NWFKIE+ + Y L++CP+ C LCR++G++ D G K LAL+D +P ++V F
Sbjct: 141 ATVGNWFKIEKADKDYVLSFCPAEACKCQTLCRELGLFVDDKGNKHLALSDQIPSFRVVF 200
Query: 197 QLA 199
+ A
Sbjct: 201 KRA 203
>Medtr6g078100.1 | Kunitz type trypsin inhibitor / miraculin | HC |
chr6:29335485-29334587 | 20130731
Length = 205
Score = 132 bits (331), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 81/186 (43%), Positives = 111/186 (59%), Gaps = 16/186 (8%)
Query: 27 PKEVFDSSGKNLRAGTQYYIIPA-SPDADGLSLANTGK------DCPLDAV--AVEGYRG 77
P+ V D SGK + G +YYI+P GL++ N CPL + +E G
Sbjct: 23 PEPVLDISGKKVTTGVKYYILPVIRGKGGGLTVVNENNLNGNNNTCPLYVLQEKLEVKNG 82
Query: 78 LPLVFTPVNPKKGVVRVDTDLNIY-FAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGD 136
+ FTP N KKGV+ TDLNI + +T+C QS VWK++ S G WF+ TGGV G+
Sbjct: 83 QAVTFTPYNAKKGVILTSTDLNIKSYVTKTTCAQSQVWKLNKVLS--GVWFLATGGVEGN 140
Query: 137 PGLQTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKR-LALTD-VP-YK 193
PG TI NWFKIE+ + Y ++CPSVC C LCR++G+Y +GK+ LAL+D VP ++
Sbjct: 141 PGFDTIFNWFKIEKADKDYVFSFCPSVC-KCQTLCRELGLYVYDHGKKHLALSDQVPSFR 199
Query: 194 VRFQLA 199
V F+ A
Sbjct: 200 VVFKRA 205
>Medtr6g065460.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:24222556-24221657 | 20130731
Length = 207
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 9/176 (5%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPA---SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVF 82
++VFD++G + G +YI+P+ + CPL + E GLP+ F
Sbjct: 28 EQVFDTNGNPIFPGGTFYIMPSIFGAAGGGLRLGKTKNSKCPLTVLQDYSEVVNGLPVKF 87
Query: 83 TPVNPKKGVVRVDTDLNIYFAAETSCPQSNVW-KVSDYDSATGQWFVTTGGVFGDPGLQT 141
T + ++ +T L+I F + C +S+ W V D++ TG W V GG + G
Sbjct: 88 TRLEAGHDIISTNTALDIAFTTKPDCAESSKWVLVDDFNKLTGPW-VGIGGTEDNEGKHI 146
Query: 142 IRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALTDV-PYKVRF 196
I +FKI+++ YKL +CP + T+ C D+G ++D G+ L L + PY+V F
Sbjct: 147 INGFFKIQKHGFGYKLVFCPDI-TAPPGACYDIGRHDDFTGRLLVLANNDPYEVVF 201
>Medtr8g461050.1 | Kunitz type trypsin inhibitor | HC |
chr8:21371027-21370419 | 20130731
Length = 202
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/176 (33%), Positives = 84/176 (47%), Gaps = 10/176 (5%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKDCPLDAVAVEGYR---GLPLVFTPVN 86
V D+SG+ + +Y+I PA G D L V +E GL LVF+P
Sbjct: 27 VIDTSGEPVEDDEEYFIRPAITGNGGRFTLVPINDACLLHVGLENADLSPGLALVFSPFA 86
Query: 87 PKKG--VVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
P VR++ DL + F A T+C QS WK+ + D+ TG+ FV G G G + N
Sbjct: 87 PHHDDDEVRLNRDLKVIFQASTACGQSTEWKLGERDATTGRRFVIIGRDSGTVG--SFGN 144
Query: 145 WFKIER--YEDAYKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+FKI + Y + +CP+ VC +C C +GI + LAL P + FQ
Sbjct: 145 FFKIVETAVRNIYNIQWCPTEVCPNCKFECGTVGIVRENGKILLALDGTPLPIVFQ 200
>Medtr3g106620.1 | Kunitz type trypsin inhibitor | HC |
chr3:49278117-49277351 | 20130731
Length = 213
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 63/187 (33%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 24 GPTPKEVFDSSGKNLRAGTQYYIIPASPDADGLSLANT-GKDCPLDAVAVEGYRGLPLVF 82
G P+ V D G L+ G YY+ P D G++L T K CPLD + G P+ F
Sbjct: 23 GDKPEAVVDKQGNPLKPGEGYYVFPLWADNGGITLGQTRNKTCPLDVIRNPEAIGSPVYF 82
Query: 83 TPVNPKKGVVRVDTDLNIYFAAETS-CPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQT 141
+ + TDL + S C + VWK+S + WFV+TGG G+
Sbjct: 83 YEY--EHDYIPTLTDLTVEIPILGSPCSERKVWKISKEGTRARFWFVSTGGFPGN----- 135
Query: 142 IRNWFKIERYE-----DAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRL----ALTDVPY 192
+ + FKIER E + Y YCPSV + LC +G + D G ++ A + PY
Sbjct: 136 LFSQFKIERLEGEHAYEIYSFLYCPSVPGT---LCAPVGTFVDTDGTKVMALGAGIEEPY 192
Query: 193 KVRFQLA 199
VRFQ A
Sbjct: 193 YVRFQKA 199
>Medtr6g066190.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:24554668-24555510 | 20130731
Length = 217
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/178 (33%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPAS--PDADGLSLANTGKD-CPLDAVAVEGYRGLPLVFTP 84
+ VFD G L G QYYI+PAS P + GL+L G CPL + GLP+ FT
Sbjct: 27 QPVFDKHGNPLTPGNQYYILPASDNPSSGGLTLDKVGDSVCPLTVLQNNAVTGLPVKFTI 86
Query: 85 VNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
+ + TDL I F + C +S+ W + D T FV GG PG++ I
Sbjct: 87 LENSTSNIVTGTDLEIEFINKPDCAESSKWLMV-VDHVTQLSFVGIGGPANYPGVELISG 145
Query: 145 WFKIERY--EDAYKLTYCPSVCTSCTHLCRDMGIYE---DQYGKRLALTDV-PYKVRF 196
F I ++ +AY++ +C C +L G+ E + G RL LT + Y V F
Sbjct: 146 KFLILKHGSGNAYRVGFCLDTTGDCAYL----GLQEFNSGEGGSRLILTAINAYSVVF 199
>Medtr6g009650.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:2916699-2917446 | 20130731
Length = 210
Score = 78.6 bits (192), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 59/175 (33%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPAS--PDADGLSLANTGK-DCPLDAVAVEGYRGLPLVFTP 84
K+V D G L G+QYYI PAS P++ GL+L G +CP+ + GLP+ FT
Sbjct: 27 KQVLDIHGTPLIPGSQYYIFPASENPNSGGLTLNKVGDLECPVTVLQNNAMIGLPVKFTV 86
Query: 85 VNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
G + TDL I F + C +S+ W + D T V GG G++TI
Sbjct: 87 PENNTGNILTGTDLEIEFTKKPDCAESSKWLMF-LDHNTQLSCVGIGGATNYHGIETISG 145
Query: 145 WFKIERYEDA--YKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALTDV-PYKVRF 196
F I ++ Y+L +C V C ++ M ++ G RL LT V Y V F
Sbjct: 146 KFLIVKHGSGHVYRLGFCLDVTGDCGYIGLQM-FNSEEGGSRLFLTAVDAYSVVF 199
>Medtr6g009563.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:2930315-2930944 | 20130731
Length = 209
Score = 78.6 bits (192), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 57/175 (32%), Positives = 84/175 (48%), Gaps = 8/175 (4%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPAS--PDADGLSLANTGK-DCPLDAVAVEGYRGLPLVFTP 84
K+V D G L G+QYYI PAS P++ GL+L G +CP+ + GLP+ FT
Sbjct: 28 KQVLDIHGTPLIPGSQYYIFPASENPNSGGLTLNKVGNLECPVTVLQNNAMIGLPVKFTI 87
Query: 85 VNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
G + TDL I F + C +++ W + D T V GG G++TI
Sbjct: 88 PENSTGNILTGTDLEIEFTKKADCAEASKW-LMFVDHNTQLSCVGIGGATNYHGIETISG 146
Query: 145 WFKIERYEDA--YKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALTDVP-YKVRF 196
F I ++ Y+L +C V +C ++ M ++ G RL LT + Y V F
Sbjct: 147 KFLIVKHGSGHVYRLGFCLDVTGNCGYIGLQM-FNSEEGGSRLFLTAIDVYSVLF 200
>Medtr0100s0150.1 | Kunitz type trypsin inhibitor | HC |
scaffold0100:33656-34541 | 20130731
Length = 201
Score = 77.4 bits (189), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 11/176 (6%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKD-CPLDAVA--VEGYRGLPLVFTPVN 86
V D+SG+ + +Y+I PA G S TG CPL EG G+ + FTP
Sbjct: 27 VIDTSGEPVEDDEEYFIRPAITGNGGGSTLVTGNGPCPLHVGLDNTEGTLGVAVKFTPFA 86
Query: 87 PKKGV--VRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
P+ VR++ DL + F TSC QS W++ + D+ +G+ + TG D G + N
Sbjct: 87 PQHDDDDVRLNRDLRVTFLTSTSCGQSTDWRLGEKDATSGRRLIVTG---RDNGAGSQGN 143
Query: 145 WFKIERYEDA--YKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+F+I + + Y + +CP+ C SC C +G+ + LAL V FQ
Sbjct: 144 FFRIVQTQTGGTYNIQWCPTEACPSCKVQCGTVGVIRENGKNLLALDGDALPVVFQ 199
>Medtr8g059790.1 | Kunitz type trypsin inhibitor | HC |
chr8:21934926-21934174 | 20130731
Length = 204
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 10/176 (5%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLS-LANTGKDCPLDA-VAVEGY-RGLPLVFTPVN 86
V D+ G+ + +Y+I P + G S + + + CPL + + G RGL + FTP
Sbjct: 29 VLDTVGEPVEGDEEYFIRPVITNKGGRSTMVSRNESCPLHVGLELTGLGRGLVVKFTPFA 88
Query: 87 PKKGV--VRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
P VRV+ DL I F A +SC QS W++ + D+ +G+ + TG G + N
Sbjct: 89 PHHDFDDVRVNRDLRITFQASSSCVQSTEWRLGEKDTKSGRRLIITGTDSATNG--SYGN 146
Query: 145 WFKIER--YEDAYKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+F+I E Y + +CP+ VC SC C + + + LAL P + FQ
Sbjct: 147 FFRIVETPLEGMYNIQWCPTEVCPSCKFECGTVDMLNENGKILLALDGGPLPLVFQ 202
>Medtr3g106585.1 | Kunitz type trypsin inhibitor | HC |
chr3:49272286-49271048 | 20130731
Length = 211
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 68/189 (35%), Positives = 92/189 (48%), Gaps = 27/189 (14%)
Query: 24 GPTPKEVFDSSGKNLRAGTQYYIIPASPDADGLSLANT-GKDCPLDAVAVEGYRGLPLVF 82
G P+ V D G L+ G YY+ P D G++L +T K CPLD + G P+ F
Sbjct: 23 GAEPEAVVDKQGNPLKPGEGYYVFPLWADNGGITLGHTRNKTCPLDVIRNPDAIGTPVYF 82
Query: 83 TPVNPKKGV--VRVDTDLNIYFAAETS-CPQSNVWKVSDYDSATGQWFVTTGGVFGDPGL 139
+ G+ + TDL I S C + VW++ S G WFV+TGG GD
Sbjct: 83 S----ASGLDYIPTLTDLTIEIPILGSPCNEPKVWRLLKVGS--GFWFVSTGGAAGD--- 133
Query: 140 QTIRNWFKIERY--EDAYKL---TYCPSVCTSCTHLCRDMGIYEDQYG-KRLALTD---V 190
+ + FKIER E AY++ +CPSV LC +G + D G K +A+ D
Sbjct: 134 --LVSKFKIERLAGEHAYEIYSFKFCPSVPGV---LCAPVGTFVDTDGTKVMAVGDGIEE 188
Query: 191 PYKVRFQLA 199
PY VRFQ A
Sbjct: 189 PYYVRFQKA 197
>Medtr2g072980.1 | Kunitz type trypsin inhibitor | HC |
chr2:30872889-30871920 | 20130731
Length = 199
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 5/149 (3%)
Query: 22 SAGPTPKEVFDSSGKNLRAGTQYYIIPASPDADG-LSLANTGKDCPL--DAVAVEGYRGL 78
SA P +EV D +G+ L +G +YYI D G ++L N CPL + +GL
Sbjct: 24 SAQPENEEVLDLTGRPLESGRKYYIRSDVSDFGGRITLVNKNGSCPLYVGQETTDFGQGL 83
Query: 79 PLVFTPVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPG 138
++ TP+ VV+V+ D + F++ +SC QS WK+ D D+ +G+ + G
Sbjct: 84 SVILTPLENDDTVVKVNRDFKVKFSSSSSCGQSTEWKLGDRDNRSGRRLIIAGS--DGNS 141
Query: 139 LQTIRNWFKIERYEDAYKLTYCPSVCTSC 167
+ ++ F IE Y + +CPS +C
Sbjct: 142 FRILKISFGIEGVIGNYNIRFCPSDTVNC 170
>Medtr7g108815.1 | Kunitz type trypsin inhibitor | HC |
chr7:44442430-44443124 | 20130731
Length = 201
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 12/166 (7%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKDCPLDAVAVEGYRGLP---LVFTPVN 86
V D++G+ + AG +Y+I P G +L CPLD V +E LP VFTP +
Sbjct: 27 VIDTNGEPVEAGDEYFIRPIITGNGGTTLVTRNGSCPLD-VGLEQNSDLPGLIAVFTPFS 85
Query: 87 PKKG--VVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
VR+ DL + F A ++C QS+ W++ + D+ +G+ +TTG G G + N
Sbjct: 86 SDHDDEDVRLSRDLRVQFLA-SNCGQSSEWRLGERDATSGRRLITTGRDDGTVG--SFGN 142
Query: 145 WFKIERYED--AYKLTYCP-SVCTSCTHLCRDMGIYEDQYGKRLAL 187
+F+I + + Y + +CP VC SC C +GI + LAL
Sbjct: 143 FFRIVQSQTLGIYNIQWCPREVCPSCWFECGTIGIIRENGKSLLAL 188
>Medtr2g073010.1 | Kunitz type trypsin inhibitor | HC |
chr2:30903185-30901231 | 20130731
Length = 198
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPASPDADG-LSLANTGKDCPLDAVAVEGY---RGLPLVFT 83
+++ D+ G L G +YYI PA D+ G +L + CPL V E +GLP++FT
Sbjct: 30 EKILDTKGHPLERGKEYYIKPAITDSGGRFTLIDRNGSCPL-YVGQENTDLGKGLPVIFT 88
Query: 84 PVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIR 143
P + V++ D + F+A + C QS WK+ D D+ +G+ + G +
Sbjct: 89 PFAKEDKVIKDSRDFKVKFSASSICVQSTEWKLGDRDTKSGRRVIIAG---------SDG 139
Query: 144 NWFKIER--YEDAYKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLAL 187
++F+I + +E Y + +CP+ C+ C C +G + LAL
Sbjct: 140 SYFRIVKAEFEGVYNIRFCPTDTCSFCRFDCGFVGGLRENGKILLAL 186
>Medtr3g014820.1 | Kunitz type trypsin inhibitor | HC |
chr3:4286399-4287257 | 20130731
Length = 203
Score = 74.3 bits (181), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 30 VFDSSGKNLRAGTQYYIIPA-SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVFTPVN 86
V D+SG+ + +Y+I PA + + G L CPL EG G+ + FTP
Sbjct: 27 VIDTSGEPVEDDEEYFIRPAITGNGGGSILVTRNGPCPLHVGLGNSEGTLGMAVKFTPFA 86
Query: 87 PKKGV----VRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTI 142
P+ VR++ DL + F T C QS W++ + D+ +G+ + TG D G +
Sbjct: 87 PRHDDDDDDVRLNRDLRVTFQGFTGCGQSTDWRLGEKDATSGRRLIVTG---RDNGAGSH 143
Query: 143 RNWFKIERYEDA--YKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
N+F+I + + Y + +CP+ C SC C +G+ + LAL V FQ
Sbjct: 144 GNFFRIVQTQTGGIYNIQWCPTEACPSCKVQCGTVGVIRENGKILLALDGGALPVVFQ 201
>Medtr3g014870.1 | Kunitz type trypsin inhibitor | HC |
chr3:4294893-4295552 | 20130731
Length = 203
Score = 73.9 bits (180), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 30 VFDSSGKNLRAGTQYYIIPA-SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVFTPVN 86
V D+SG+ + +Y+I PA + + G L CPL EG G+ + FTP
Sbjct: 27 VIDTSGEPVEDDEEYFIRPAITGNGGGSILVTRNAPCPLHVGLGNSEGTLGVAVKFTPFA 86
Query: 87 PKKGV----VRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTI 142
P+ VR++ DL + F T C QS W++ + D+ +G+ + TG D G +
Sbjct: 87 PRHDDDDDDVRLNRDLRVTFQGFTGCGQSTDWRLGEKDATSGRRLIVTG---RDNGAGSH 143
Query: 143 RNWFKIERYEDA--YKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
N+F+I + + Y + +CP+ C SC C +G+ + LAL V FQ
Sbjct: 144 GNFFRIVQTQTGGIYNIQWCPTEACPSCKVQCGTVGVIRENGKILLALDGGALPVVFQ 201
>Medtr8g461690.1 | Kunitz type trypsin inhibitor | HC |
chr8:21798774-21797953 | 20130731
Length = 200
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 8/174 (4%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKDCPLD-AVAVEGYRGLPLVFTPV--N 86
V D+SG+ + Y+I PA G T CP + + + +G ++ +P N
Sbjct: 27 VIDTSGEPVENDEDYFIRPAITGNGGSLTLVTRNSCPFNVGLDPDAPQGFAVLLSPFVSN 86
Query: 87 PKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRNWF 146
++ VR+ DL + F A TSC QS W++ + D+ TG+ F+ TG D + + N+F
Sbjct: 87 REEDEVRLGRDLRVIFQAGTSCGQSTEWRLGERDATTGRRFIITGR--DDSTVGSYGNFF 144
Query: 147 KIER--YEDAYKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+I + + + +CP+ VC SC C +GI + LAL V FQ
Sbjct: 145 RIVQTPSRGIFNIQWCPTEVCPSCKFECGTVGIVRENGKILLALDGSALPVAFQ 198
>Medtr8g060550.1 | Kunitz type trypsin inhibitor | HC |
chr8:21404261-21403659 | 20130731
Length = 200
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 8/174 (4%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKDCPLD-AVAVEGYRGLPLVFTPV--N 86
V D+SG+ + Y+I PA G T CP + + + +G ++ +P N
Sbjct: 27 VIDTSGEPVENDEDYFIRPAITGNGGSLTLVTRNSCPFNVGLDPDAPQGFAVLLSPFVSN 86
Query: 87 PKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRNWF 146
++ VR+ DL + F A TSC QS W++ + D+ TG+ F+ TG D + + N+F
Sbjct: 87 REEDEVRLGRDLRVIFQAGTSCGQSTEWRLGERDATTGRRFIITGR--DDSTVGSYGNFF 144
Query: 147 KIER--YEDAYKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+I + + + +CP+ VC SC C +GI + LAL V FQ
Sbjct: 145 RIVQTPSRGIFNIQWCPTEVCPSCKFECGTVGIVRENGKILLALDGSALPVAFQ 198
>Medtr0302s0030.1 | Kunitz type trypsin inhibitor | HC |
scaffold0302:15385-14777 | 20130731
Length = 202
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKD-CPLDAVA--VEGYRGLPLVFTPVN 86
V D+SG+ + +Y+I PA G S TG CPL EG G+ + FTP
Sbjct: 27 VIDTSGEPVEDDEEYFIRPAIGGNGGGSTLVTGNGPCPLHVGLDNSEGTLGVAVKFTPFA 86
Query: 87 PKKG--VVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
P VR++ DL + F TSC QS W++ + D+ +G+ + TG Q N
Sbjct: 87 PHHDDDNVRLNRDLRVTFLTSTSCGQSTDWRLGEKDATSGRRLIVTGRDNSAGSQQG--N 144
Query: 145 WFKIERYEDA--YKLTYCPS-VCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+F+I + + + Y + +CP+ VC +C + C +G+ + LAL V FQ
Sbjct: 145 FFRIVQTQTSGNYNIQWCPTEVCPNCKNQCGTVGLIRENGKILLALDGGALPVVFQ 200
>Medtr6g059650.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:20461180-20460270 | 20130731
Length = 211
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 94/179 (52%), Gaps = 13/179 (7%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPASPDA--DGLSLANTGKD-CPLDAVA--VEGYRGLPLVF 82
++V DS+G + +++Y+ P+ A G+ L TG CPL + E GLP+ F
Sbjct: 26 EQVRDSNGNPIFFSSRFYVKPSIFGAAGGGVKLGETGNSSCPLTVLQDYSEVVNGLPVKF 85
Query: 83 TPVNPKKGVVRVDTD---LNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGL 139
+ + + + + TD ++I F + C +S+ W + + D W V GG+ G
Sbjct: 86 S-TDAEIFIDLISTDTSRVDIVFPEKPECAESSKWLLIE-DDFPRPW-VGIGGIEDYIGK 142
Query: 140 QTIRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALT-DVPYKVRFQ 197
I FKI ++ YKL +CP+ T+ LC D+G Y+D+ G+RL LT D PY+V F+
Sbjct: 143 HIIDGKFKIVKHGFGYKLVFCPTF-TAPPGLCHDIGRYDDKNGRRLILTEDDPYEVVFE 200
>Medtr0211s0080.1 | Kunitz type trypsin inhibitor | HC |
scaffold0211:26510-25794 | 20130731
Length = 198
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 14/176 (7%)
Query: 30 VFDSSGKNLRAGTQYYIIPA-SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVFTPVN 86
V D+SG+ + +Y+I PA + + G +L CPL+ EG G+ + FTP
Sbjct: 27 VIDTSGEPVEDDEEYFIRPAITGNGGGFTLITGNGPCPLNVGLDNTEGTLGVAVKFTPFA 86
Query: 87 PKKG--VVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
P V ++ DL + F TSC QS W++ + D+ +G+ + TG + N
Sbjct: 87 PHHDDDNVGLNRDLRVTFLTSTSCGQSTDWRLGEKDATSGRRLIVTGRDNAEG------N 140
Query: 145 WFKIERYEDA--YKLTYCP-SVCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+F+I + + Y + +CP VC SC C +G+ + LAL V FQ
Sbjct: 141 FFRIVQTQTGGNYNIQWCPKEVCPSCNIQCGTVGVIRENGKILLALDGGALPVVFQ 196
>Medtr0084s0030.1 | Kunitz type trypsin inhibitor | HC |
scaffold0084:16850-17730 | 20130731
Length = 202
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 10/176 (5%)
Query: 30 VFDSSGKNLRAGTQYYIIPA-SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVFTPVN 86
V D+SG+ + +Y+I PA + + G + CPL+ EG G P+ F P
Sbjct: 27 VIDTSGEPVEDDEEYFIRPAITGNGGGFTFITGNGPCPLNVGLDNTEGTLGAPVKFIPFA 86
Query: 87 PKKG--VVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
V ++ DL + F TSC S W + + D+ +G+ + TGG G Q N
Sbjct: 87 SHHDDFNVGLNRDLRVTFLTSTSCGNSRDWTLGEKDATSGRRLIVTGGDNGAGSQQG--N 144
Query: 145 WFKIERYEDA--YKLTYCP-SVCTSCTHLCRDMGIYEDQYGKRLALTDVPYKVRFQ 197
+F+I + + + Y + +CP VC SC C +G+ + LAL V FQ
Sbjct: 145 FFRIVQTQTSGNYNIQWCPKEVCPSCNIQCGTVGVIRENGKILLALDGRALPVVFQ 200
>Medtr6g017225.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:6869867-6868228 | 20130731
Length = 375
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 46/137 (33%), Positives = 73/137 (53%), Gaps = 6/137 (4%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPASPD--ADGLSLANTG-KDCPLDAVAVEGYRGLPLVFTP 84
++V D++G + G +YYI PA+ D GL LA TG CP+ + E GLP+ FT
Sbjct: 28 EQVLDTNGNPIVPGGEYYIFPATQDPYKGGLRLAKTGDSKCPVTILQNENITGLPVKFTI 87
Query: 85 VNPKKGVVRVDTDLNIYFAAETSCPQSNVWKV-SDYDSATGQWFVTTGGVFGDPGLQTIR 143
++ T+L I F + +C +S+ W + DYD+++ + V G P + I
Sbjct: 88 QGISNDIIMTGTELKIEFTKKPNCVKSSQWLMFFDYDASS--FNVIIGVDEYIPEIIIID 145
Query: 144 NWFKIERYEDAYKLTYC 160
F I++Y +AYKL +C
Sbjct: 146 GTFYIQKYGNAYKLGFC 162
>Medtr6g059680.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:20475350-20476274 | 20130731
Length = 220
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 9/177 (5%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPA---SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVF 82
++V D +G + G +YYI+PA ++ DC + V E G+P+ F
Sbjct: 30 EQVLDINGNPIFPGGKYYILPAIRGPLGGGLRLGKSSNSDCEVTVVQDYNEVINGVPVKF 89
Query: 83 TPVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTI 142
+ G++ T ++I F + +C +S+ W + DS + V GG PG +T+
Sbjct: 90 SIPEISPGIIFTGTPIDIEFTKKPNCVESSKWLIF-VDSVIQKACVGIGGPENYPGFRTL 148
Query: 143 RNWFKIERYED--AYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALT-DVPYKVRF 196
F IE++E Y+L YC +C + R ED+ G RL LT V + V F
Sbjct: 149 SGTFNIEKHESGFGYRLGYCVKDSPTCLDIGRAHEEVEDEGGSRLHLTHQVAFAVVF 205
>Medtr6g066210.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:24566372-24567281 | 20130731
Length = 216
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 10/177 (5%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPAS--PDADGLSLANTGK-DCPLDAVAVEGYRGLPLVFTP 84
++V D +G L G QYYI+P S P GL L +CP+ V GLP+ F+
Sbjct: 27 EQVLDINGTPLTPGGQYYILPESDNPSIGGLILNKIDDLECPVTVVQDITVIGLPVKFSM 86
Query: 85 VNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
+ + TDL I F + C +S+ W + D T FV GG +PG++T
Sbjct: 87 LENSTSNILPGTDLEIEFTTKPDCAKSSKWSMF-VDHDTQLSFVGIGGSANNPGVETTSG 145
Query: 145 WFKIERYE----DAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALT-DVPYKVRF 196
F + +++ AY++ +C C + + ED G RL T + Y V F
Sbjct: 146 KFLVVKHQHGSGHAYRIGFCLDTTGDCGFIALEFFNSEDG-GPRLIFTVNDAYSVVF 201
>Medtr6g059730.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:20493190-20494222 | 20130731
Length = 216
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 10/176 (5%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPA---SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVF 82
++V D +G + G QYYI+PA CP+ + E GLP+ F
Sbjct: 29 EQVLDINGNPIFPGGQYYILPALRGPGGGGVRLGRTGDLKCPVTVLQDRREVKNGLPVKF 88
Query: 83 TPVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTI 142
T G++ T L I + + SC S W + D+ G+ + GG PG+QT+
Sbjct: 89 TIPGISPGIIFTGTPLEIEYTKKPSCAASTKWLIF-VDNVIGKACIGIGGPENYPGVQTL 147
Query: 143 RNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYE-DQYGKRLALTDVP-YKVRF 196
+ F I+++ + Y C + + C D+G ++ D+ G+RL LT+ Y+V F
Sbjct: 148 KGKFNIQKHASGFG--YNLGFCVTGSPTCLDIGRFDNDEAGRRLNLTEHEVYQVVF 201
>Medtr6g059760.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:20502091-20503124 | 20130731
Length = 213
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 14/177 (7%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPASPDADGLSLANTGKDCPL--DAVAVEGYRGLPLVFTPV 85
++V D +G + +Y+I PA GL L T + CPL E + LPL F P
Sbjct: 29 EQVKDKNGNPILVSKKYFIWPADGSGGGLRLNET-EQCPLVVQQAFSEDVKSLPLKFIPT 87
Query: 86 -NPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN 144
N + T L+I F +T C +S+ W V W GGV G I
Sbjct: 88 ENINDFIFTGYTSLDIVFEKKTKCAESSKWVVVK-GGFMEPWIGIGGGVNGK---SVIDG 143
Query: 145 WFKIE--RYEDAYKLTYCPSVCTSCTHLCRDMG-IYEDQYGKRLALTD--VPYKVRF 196
FKIE R YKL +CP++ + T C ++G ++++ G RL +++ P++V F
Sbjct: 144 LFKIETIRSFRGYKLVFCPTI-SDPTGQCNNIGRFFDNENGLRLIMSENFKPFEVVF 199
>Medtr6g078040.1 | kunitz family trypsin and protease inhibitor
protein | LC | chr6:29318348-29317920 | 20130731
Length = 94
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 33/76 (43%), Positives = 48/76 (63%), Gaps = 4/76 (5%)
Query: 91 VVRVDTDLNI-YFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTIRN-WFKI 148
++ TDLNI + +T+C QS VW++S S G WF +T GV G+P T + WFKI
Sbjct: 1 MILTSTDLNIKSYVTKTTCAQSQVWQLSKVLS--GVWFFSTEGVEGNPCFNTNKEYWFKI 58
Query: 149 ERYEDAYKLTYCPSVC 164
E+ ++ Y L++CP VC
Sbjct: 59 EKADNDYVLSFCPLVC 74
>Medtr6g059530.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:20434050-20432791 | 20130731
Length = 203
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 18/178 (10%)
Query: 28 KEVFDSSGKNLRAGTQYYIIP---ASPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVF 82
+ V D +G + G +YYI P +CP+ + E RGLP+ F
Sbjct: 24 ETVEDINGNPVFPGGKYYIAPLISKGGGGGLKLGKTGDSECPVTVLQDFSEVVRGLPVRF 83
Query: 83 TPVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTI 142
T + K+GV+ +++I F + C +S W ++ D F T+ GD +
Sbjct: 84 T-IIVKRGVIFTTDEVDIEFVKKPKCAESAKWVLAHDD------FPTSWVGIGD-NIDAF 135
Query: 143 RNWFKIERY---EDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALTDV-PYKVRF 196
+ FKIE AYKL YCP + ++ C D+G Y D+ G RL T+ P++V F
Sbjct: 136 QGKFKIETLGSGSGAYKLVYCP-LFSAPPGACSDIGRYRDENGWRLVPTENDPFRVVF 192
>Medtr6g059410.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:20401738-20400851 | 20130731
Length = 202
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 18/178 (10%)
Query: 28 KEVFDSSGKNLRAGTQYYIIP---ASPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVF 82
+ V D +G + G +YYI P +CP+ + E RG P+ F
Sbjct: 23 ETVEDINGNPVFPGGKYYIAPLISKGGGGGLKLGKTGDSECPVTVIQDFSEVVRGFPVRF 82
Query: 83 TPVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDPGLQTI 142
+ ++GV+ +L+I F + C +S W ++ D F T+ GD +
Sbjct: 83 I-IRVRRGVIFTTDELDIEFVKKPKCAESAKWVLAHDD------FPTSWVGIGD-NIDAF 134
Query: 143 RNWFKIERY---EDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALTDV-PYKVRF 196
+ FKIE AYKL YCP + ++ C D+G Y D+ G RL T+ P++V F
Sbjct: 135 QGKFKIETLGSGSGAYKLVYCP-LFSAPPGACSDIGRYRDENGWRLVPTENDPFRVVF 191
>Medtr6g065460.2 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:24222549-24221721 | 20130731
Length = 183
Score = 54.3 bits (129), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 33/176 (18%)
Query: 28 KEVFDSSGKNLRAGTQYYIIPA---SPDADGLSLANTGKDCPLDAVA--VEGYRGLPLVF 82
++VFD++G + G +YI+P+ + CPL + E GLP+ F
Sbjct: 28 EQVFDTNGNPIFPGGTFYIMPSIFGAAGGGLRLGKTKNSKCPLTVLQDYSEVVNGLPVKF 87
Query: 83 TPVNPKKGVVRVDTDLNIYFAAETSCPQSNVW-KVSDYDSATGQWFVTTGGVFGDPGLQT 141
T + ++ +T L+I F + C +S+ W V D++ TG W V GG
Sbjct: 88 TRLEAGHDIISTNTALDIAFTTKPDCAESSKWVLVDDFNKLTGPW-VGIGGT-------- 138
Query: 142 IRNWFKIERYEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALTDV-PYKVRF 196
ED +T P C D+G ++D G+ L L + PY+V F
Sbjct: 139 ----------EDNEDITAPPGA-------CYDIGRHDDFTGRLLVLANNDPYEVVF 177
>Medtr6g059810.1 | Kunitz type trypsin inhibitor / Alpha-fucosidase
| HC | chr6:20517286-20517927 | 20130731
Length = 213
Score = 48.9 bits (115), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 30 VFDSSGKNLRAGTQYYIIPASPDADGLSLANT-GKDCPL-----DAVAVEGYRGLPLVFT 83
V D +G L GT YYI PA+ ++L T DC D + G R + +
Sbjct: 35 VVDKNGIPLIPGTSYYISPANTGGR-ITLGKTVDSDCSFLVLQDDEKMIYG-RQVKFSLS 92
Query: 84 PVNPKKGVVRVDTDLNIYFAAETSCPQSNVWKVSDYDSATGQWFVTTGGVFGDP-GLQTI 142
++ +T L+I F + SC +S+ W + + + FV GG P G Q +
Sbjct: 93 VGIIPASLIFTNTALDIEFVYKDSCVESSKWLIFVDNVNNNKSFVGIGGPENYPQGTQIL 152
Query: 143 RNWFKIER--YEDAYKLTYCPSVCTSCTHLCRDMGIYEDQYGKRLALT 188
F I++ E+AYK +C SC + R M I E+ G+RL+
Sbjct: 153 NGKFNIKKSGSENAYKFGFCVKETPSCWDIGRYMSIGEEG-GRRLSFN 199